# SvO2 Trigger in Transfusion Strategy After Cardiac Surgery

> **NCT02761564** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 100 (actual)

## Conditions studied

- Undergoing Nonemergent Cardiac Surgery
- Central Venous Catheter on the Superior Vena Cava (to Perform ScVO2 Measure)
- Anemia (<9g/dL) Requiring Blood Transfusion
- Hemodynamic and Respiratory Stability
- Bleeding Graded as Insignificant, Mild, Moderate of Universal Definition of Perioperative Bleeding

## Interventions

- **OTHER:** Red blood cell tranfusion
- **OTHER:** ScvO2 measure

## Key facts

- **NCT ID:** NCT02761564
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-06
- **Primary completion:** 2018-09-17
- **Final completion:** 2018-10-17
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2019-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02761564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02761564, "SvO2 Trigger in Transfusion Strategy After Cardiac Surgery". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02761564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
